Financials Lantheus Holdings, Inc.

Equities

LNTH

US5165441032

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
76.02 USD +0.16% Intraday chart for Lantheus Holdings, Inc. +0.65% +22.61%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 805 902.1 1,956 3,439 4,246 5,269 - -
Enterprise Value (EV) 1 906.1 1,041 1,956 3,439 4,246 5,269 5,269 5,269
P/E ratio - - -27.3 x 127 x 13.3 x 12.4 x 12.6 x 9.59 x
Yield - - - - - - - -
Capitalization / Revenue 2.32 x 2.66 x 4.6 x 3.68 x 3.28 x 3.51 x 3.35 x 2.9 x
EV / Revenue 2.32 x 2.66 x 4.6 x 3.68 x 3.28 x 3.51 x 3.35 x 2.9 x
EV / EBITDA 9.59 x 15.3 x 19.6 x 7.62 x 7.01 x 7.39 x 7.44 x 6.85 x
EV / FCF 13.8 x 230 x - 13.1 x - 6.78 x 7.7 x 8.21 x
FCF Yield 7.25% 0.43% - 7.66% - 14.7% 13% 12.2%
Price to Book 7.18 x 1.75 x - - - - - -
Nbr of stocks (in thousands) 39,248 66,871 67,691 67,493 68,489 69,313 - -
Reference price 2 20.51 13.49 28.89 50.96 62.00 76.02 76.02 76.02
Announcement Date 2/25/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 347.3 339.4 425.2 935.1 1,296 1,502 1,571 1,815
EBITDA 1 83.96 58.87 99.71 451.3 605.6 713.2 708.6 769.2
EBIT 1 72.38 34.18 57.79 403.4 545.6 653.1 633.9 717
Operating Margin 20.84% 10.07% 13.59% 43.14% 42.08% 43.48% 40.35% 39.51%
Earnings before Tax (EBT) 1 28.63 -11.48 -75.04 26.72 410.9 533.7 560.3 807.4
Net income 1 31.67 -13.47 -71.28 28.07 326.7 437.1 438.9 586.4
Net margin 9.12% -3.97% -16.76% 3% 25.2% 29.1% 27.94% 32.31%
EPS 2 - - -1.060 0.4000 4.650 6.132 6.025 7.928
Free Cash Flow 1 58.32 3.922 - 263.4 - 777.1 684 642
FCF margin 16.79% 1.16% - 28.17% - 51.74% 43.54% 35.37%
FCF Conversion (EBITDA) 69.47% 6.66% - 58.37% - 108.95% 96.53% 83.46%
FCF Conversion (Net income) 184.18% - - 938.59% - 177.79% 155.85% 109.49%
Dividend per Share - - - - - - - -
Announcement Date 2/25/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 129.6 208.9 223.7 239.3 263.2 300.8 321.7 319.9 354 370 377.7 374.5 383.4 371.5 379.6
EBITDA 1 40.4 95.79 91.91 114.4 132.2 156.6 165.8 154.2 180.8 170.7 184.4 179.6 191.1 180.7 187.7
EBIT 1 28.2 92.69 88.61 102.2 120.4 142 150.1 139.5 165.7 155.3 167.7 163.5 173 154.5 161.2
Operating Margin 21.76% 44.37% 39.61% 42.72% 45.73% 47.21% 46.65% 43.61% 46.82% 41.97% 44.41% 43.64% 45.12% 41.6% 42.47%
Earnings before Tax (EBT) 1 -41.01 57.9 62.04 83.02 -176.2 -11.1 123.7 160 138.4 171.3 162.3 161.3 146.6 151 88.05
Net income 1 -40.22 42.96 43.06 61.23 -119.2 -2.807 94.13 132 103.4 131.1 108.2 108.6 102.4 112.5 67.53
Net margin -31.04% 20.57% 19.25% 25.59% -45.29% -0.93% 29.26% 41.24% 29.2% 35.43% 28.66% 29% 26.7% 30.29% 17.79%
EPS 2 -0.5900 0.6100 0.6100 0.8600 -1.740 -0.0400 1.330 1.880 1.470 1.870 1.526 1.520 1.414 1.563 0.9200
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/24/22 4/29/22 8/4/22 11/3/22 2/23/23 5/4/23 8/3/23 11/2/23 2/22/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 101 139 - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 1.205 x 2.358 x - - - - - -
Free Cash Flow 1 58.3 3.92 - 263 - 777 684 642
ROE (net income / shareholders' equity) 50.6% 8.21% - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2.860 7.690 - - - - - -
Cash Flow per Share - 0.3000 - - - - - -
Capex 1 22.1 12.5 - 18.3 46.6 51.3 59.8 72
Capex / Sales 6.35% 3.68% - 1.96% 3.59% 3.41% 3.8% 3.97%
Announcement Date 2/25/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
76.02 USD
Average target price
104.9 USD
Spread / Average Target
+37.99%
Consensus
  1. Stock Market
  2. Equities
  3. LNTH Stock
  4. Financials Lantheus Holdings, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW